ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,964 | -59.5% | 778 | -52.0% | 0.00% | – |
Q2 2023 | $34,470 | +85.0% | 1,620 | +51.4% | 0.00% | – |
Q1 2023 | $18,635 | -31.0% | 1,070 | -18.6% | 0.00% | – |
Q4 2022 | $27,000 | +3.8% | 1,315 | +31.5% | 0.00% | – |
Q3 2022 | $26,000 | -3.7% | 1,000 | 0.0% | 0.00% | – |
Q2 2022 | $27,000 | -97.2% | 1,000 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $971,000 | +2211.9% | 1,000 | 0.0% | 0.00% | – |
Q4 2021 | $42,000 | -4.5% | 1,000 | -20.3% | 0.00% | – |
Q3 2021 | $44,000 | +25.7% | 1,255 | 0.0% | 0.00% | – |
Q2 2021 | $35,000 | -5.4% | 1,255 | 0.0% | 0.00% | – |
Q1 2021 | $37,000 | -22.9% | 1,255 | -32.4% | 0.00% | – |
Q4 2020 | $48,000 | +242.9% | 1,856 | +121.0% | 0.00% | – |
Q3 2020 | $14,000 | -30.0% | 840 | +6.3% | 0.00% | – |
Q2 2020 | $20,000 | +81.8% | 790 | 0.0% | 0.00% | – |
Q1 2020 | $11,000 | – | 790 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |